181 related articles for article (PubMed ID: 16870432)
21. 4-arylphthalazin-1(2H)-one derivatives as potent antagonists of the melanin concentrating hormone receptor 1 (MCH-R1).
Lim CJ; Kim SH; Lee BH; Oh KS; Yi KY
Bioorg Med Chem Lett; 2012 Jan; 22(1):427-30. PubMed ID: 22137790
[TBL] [Abstract][Full Text] [Related]
22. A new strategy to improve the predictive ability of the local lazy regression and its application to the QSAR study of melanin-concentrating hormone receptor 1 antagonists.
Li J; Li S; Lei B; Liu H; Yao X; Liu M; Gramatica P
J Comput Chem; 2010 Apr; 31(5):973-85. PubMed ID: 19670228
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and SAR of 4-aryl-1-(indazol-5-yl)pyridin-2(1H)ones as MCH-1 antagonists for the treatment of obesity.
Hadden M; Deering DM; Henderson AJ; Surman MD; Luche M; Khmelnitsky Y; Vickers S; Viggers J; Cheetham S; Guzzo PR
Bioorg Med Chem Lett; 2010 Dec; 20(23):7020-3. PubMed ID: 20951036
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of novel hydantoin-containing melanin-concentrating hormone receptor antagonists.
Balavoine F; Malabre P; Alleaume T; Rey A; Cherfils V; Jeanneton O; Seigneurin-Venin S; Revah F
Bioorg Med Chem Lett; 2007 Jul; 17(13):3754-9. PubMed ID: 17448659
[TBL] [Abstract][Full Text] [Related]
25. A virtual screening approach to finding novel and potent antagonists at the melanin-concentrating hormone 1 receptor.
Clark DE; Higgs C; Wren SP; Dyke HJ; Wong M; Norman D; Lockey PM; Roach AG
J Med Chem; 2004 Jul; 47(16):3962-71. PubMed ID: 15267235
[TBL] [Abstract][Full Text] [Related]
26. Lead optimization of 4-(dimethylamino)quinazolines, potent and selective antagonists for the melanin-concentrating hormone receptor 1.
Kanuma K; Omodera K; Nishiguchi M; Funakoshi T; Chaki S; Semple G; Tran TA; Kramer B; Hsu D; Casper M; Thomsen B; Sekiguchi Y
Bioorg Med Chem Lett; 2005 Sep; 15(17):3853-6. PubMed ID: 16002290
[TBL] [Abstract][Full Text] [Related]
27. Discovery and characterization of aminopiperidinecoumarin melanin concentrating hormone receptor 1 antagonists.
Kym PR; Iyengar R; Souers AJ; Lynch JK; Judd AS; Gao J; Freeman J; Mulhern M; Zhao G; Vasudevan A; Wodka D; Blackburn C; Brown J; Che JL; Cullis C; Lai SJ; LaMarche MJ; Marsilje T; Roses J; Sells T; Geddes B; Govek E; Patane M; Fry D; Dayton BD; Brodjian S; Falls D; Brune M; Bush E; Shapiro R; Knourek-Segel V; Fey T; McDowell C; Reinhart GA; Preusser LC; Marsh K; Hernandez L; Sham HL; Collins CA
J Med Chem; 2005 Sep; 48(19):5888-91. PubMed ID: 16161992
[TBL] [Abstract][Full Text] [Related]
28. Optimization of piperidin-4-yl-urea-containing melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Reducing hERG-associated liabilities.
Berglund S; Egner BJ; Gradén H; Gradén J; Morgan DG; Inghardt T; Giordanetto F
Bioorg Med Chem Lett; 2009 Aug; 19(15):4274-9. PubMed ID: 19500982
[TBL] [Abstract][Full Text] [Related]
29. Novel benzimidazole-based MCH R1 antagonists.
Carpenter AJ; Al-Barazanji KA; Barvian KK; Bishop MJ; Britt CS; Cooper JP; Goetz AS; Grizzle MK; Hertzog DL; Ignar DM; Morgan RO; Peckham GE; Speake JD; Swain WR
Bioorg Med Chem Lett; 2006 Oct; 16(19):4994-5000. PubMed ID: 16904318
[TBL] [Abstract][Full Text] [Related]
30. 5-(pyridinon-1-yl)indazoles and 5-(furopyridinon-5-yl)indazoles as MCH-1 antagonists.
Surman MD; Freeman EE; Grabowski JF; Hadden M; Henderson AJ; Jiang G; Jiang XM; Luche M; Khmelnitsky Y; Vickers S; Viggers J; Cheetham S; Guzzo PR
Bioorg Med Chem Lett; 2010 Dec; 20(23):7015-9. PubMed ID: 20961756
[TBL] [Abstract][Full Text] [Related]
31. 4-Acylamino-and 4-ureidobenzamides as melanin-concentrating hormone (MCH) receptor 1 antagonists.
Receveur JM; Bjurling E; Ulven T; Little PB; Nørregaard PK; Högberg T
Bioorg Med Chem Lett; 2004 Oct; 14(20):5075-80. PubMed ID: 15380202
[TBL] [Abstract][Full Text] [Related]
32. Melanin concentrating hormone receptor antagonists as antiobesity agents: from M2 to MCHR-1.
McBriar MD
Curr Top Med Chem; 2007; 7(15):1440-54. PubMed ID: 17897031
[TBL] [Abstract][Full Text] [Related]
33. Optimization of a series of quinazolinone-derived antagonists of CXCR3.
Liu J; Fu Z; Li AR; Johnson M; Zhu L; Marcus A; Danao J; Sullivan T; Tonn G; Collins T; Medina J
Bioorg Med Chem Lett; 2009 Sep; 19(17):5114-8. PubMed ID: 19632842
[TBL] [Abstract][Full Text] [Related]
34. Melanin-concentrating hormone receptor 1 antagonists: synthesis, structure-activity relationship, docking studies, and biological evaluation of 2,3,4,5-tetrahydro-1H-3-benzazepine derivatives.
Kasai S; Kamaura M; Kamata M; Aso K; Ogino H; Nakano Y; Watanabe K; Kaisho T; Tawada M; Nagisa Y; Takekawa S; Kato K; Suzuki N; Ishihara Y
Bioorg Med Chem; 2011 Nov; 19(21):6261-73. PubMed ID: 21975069
[TBL] [Abstract][Full Text] [Related]
35. Discovery of potent and stable conformationally constrained analogues of the MCH R1 antagonist SB-568849.
Witty DR; Bateson J; Hervieu GJ; Al-Barazanji K; Jeffrey P; Hamprecht D; Haynes A; Johnson CN; Muir AI; O'Hanlon PJ; Stemp G; Stevens AJ; Thewlis K; Winborn KY
Bioorg Med Chem Lett; 2006 Sep; 16(18):4872-8. PubMed ID: 16839763
[TBL] [Abstract][Full Text] [Related]
36. Discovery of cyclopentane- and cyclohexane-trans-1,3-diamines as potent melanin-concentrating hormone receptor 1 antagonists.
Giordanetto F; Karlsson O; Lindberg J; Larsson LO; Linusson A; Evertsson E; Morgan DG; Inghardt T
Bioorg Med Chem Lett; 2007 Aug; 17(15):4232-41. PubMed ID: 17532215
[TBL] [Abstract][Full Text] [Related]
37. The melanin-concentrating hormone receptor 2 (MCH-R2) mediates the effect of MCH to control body color for background adaptation in the barfin flounder.
Takahashi A; Kosugi T; Kobayashi Y; Yamanome T; Schiöth HB; Kawauchi H
Gen Comp Endocrinol; 2007 Apr; 151(2):210-9. PubMed ID: 17324419
[TBL] [Abstract][Full Text] [Related]
38. SAR study of bicyclo[4.1.0]heptanes as melanin-concentrating hormone receptor R1 antagonists: taming hERG.
Su J; McKittrick BA; Tang H; Burnett DA; Clader JW; Greenlee WJ; Hawes BE; O'Neill K; Spar B; Weig B; Kowalski T; Sorota S; Li C; Liu T
Bioorg Med Chem; 2007 Aug; 15(16):5369-85. PubMed ID: 17572094
[TBL] [Abstract][Full Text] [Related]
39. Thienopyrimidinone bis-aminopyrrolidine ureas as potent melanin-concentrating hormone receptor-1 (MCH-R1) antagonists.
Zhang M; Tamiya J; Nguyen L; Rowbottom MW; Dyck B; Vickers TD; Grey J; Schwarz DA; Heise CE; Haelewyn J; Mistry MS; Goodfellow VS
Bioorg Med Chem Lett; 2007 May; 17(9):2535-9. PubMed ID: 17329101
[TBL] [Abstract][Full Text] [Related]
40. Identification of a new small molecule chemotype of Melanin Concentrating Hormone Receptor-1 antagonists using pharmacophore-based virtual screening.
Helal MA; Chittiboyina AG; Avery MA
Bioorg Med Chem Lett; 2019 Dec; 29(24):126741. PubMed ID: 31678007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
